Tag: Novo Nordisk

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Novo Nordisk

Novo Nordisk Invests DKK 8.5 Billion to Build New Manufacturing Facility for Rare Disease ...

Added to Collection on: 2024-12-16 19:43:20

Tags for this article:

Novo Nordisk
Catalent
Novo Holdings A/S
Novo
NNE
Ant
Nordisk
Denmark
Novo Nordisk A/S

Click the tags to see associated articles and topics

View Article Details
Novo's Ozempic under spotlight: Danish studies link diabetes drug to rare eye disease

Added to Collection on: 2024-12-17 22:43:00

Tags for this article:

Peptide hormones
Eye diseases
PEPTIDE THERAPEUTICS
In Denmark
In science
Semaglutide
Non-arteritic anterior ischemic optic neuropathy
Anterior ischemic optic neuropathy
Novo Nordisk
GLP-1 receptor agonist
Optic neuropathy
Arteritic anterior ischemic optic neuropathy
university of southern denmark

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk Seeks to Block Compounded Versions of Diabetes / Weight Loss Drug

Added to Collection on: 2024-12-17 20:22:41

Tags for this article:

Pharmaceuticals policy
Pharmacy
Compounding
PEPTIDE THERAPEUTICS
Drug Quality and Security Act
Semaglutide
Federal Food, Drug, and Cosmetic Act
Novo Nordisk
Food and Drug Administration
Pharmaceutical industry
NORDISK INC.
NOVO NORDISK INC

Click the tags to see associated articles and topics

View Article Details
Beyond the Prescription: Ozempic's Influence on Health, Retail, and Consumer Behavior

Added to Collection on: 2024-12-24 15:42:44

Tags for this article:

Peptide hormones
In Denmark
In science
Semaglutide
Diets
GLP-1 receptor agonist
Noom
Anti-obesity medication
Novo Nordisk
Glucagon-like peptide-1
Addiction
Diabetes
United States

Click the tags to see associated articles and topics

View Article Details
Opinion: We've accepted Wegovy and Zepbound. The next phase is harder.

Added to Collection on: 2024-12-25 17:40:33

Tags for this article:

Body shape
Peptide hormones
Human body weight
Obesity
Classification of obesity
Anti-obesity medication
Semaglutide
Body mass index
Weight loss
Overweight
Sleep apnea
Glucagon-like peptide-1
Eli Lilly & Co.
Novo Nordisk

Click the tags to see associated articles and topics

View Article Details
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades - The Globe and Mail

Added to Collection on: 2024-12-28 13:32:13

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Eli Lilly and Company
Research and development in the United States
Novo Nordisk
GLP-1 receptor agonist
Semaglutide
Tirzepatide
Eli Lilly
Anti-obesity medication
Insulin
Cagrilintide/semaglutide

Click the tags to see associated articles and topics

View Article Details
Eli Lilly, Novo Nordisk Went Head-to-Head on Weight-Loss Drugs in 2024. There's a Clear Winner.

Added to Collection on: 2024-12-31 14:53:12

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
Eli Lilly and Company
Novo Nordisk
Cagrilintide/semaglutide
Tirzepatide
Glucagon-like peptide-1
Anti-obesity medication
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
A massive diabetes challenge and pharma-tech moonshots, Europe starts 2025 in launch mode

Added to Collection on: 2025-01-01 10:45:43

Tags for this article:

Peptide hormones
PEPTIDE THERAPEUTICS
Anti-diabetic drugs
Insulin delivery
Diabetes
Insulin
GLP-1 receptor agonist
Semaglutide
Type 2 diabetes
Novo Nordisk
Glucagon-like peptide-1
Blood glucose monitoring

Click the tags to see associated articles and topics

View Article Details
Client Novo Nordisk Expands AI-Based Cardiometabolic Drug Discovery Collaboration with ...

Added to Collection on: 2025-01-09 16:52:30

Tags for this article:

Novo Nordisk
Royalty payment
Novo Nordisk Foundation
Ropes & Gray

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma Provides Business and Strategic Roadmap - GlobeNewswire

Added to Collection on: 2025-01-12 22:02:39

Tags for this article:

Pharmaceuticals policy
Food and Drug Administration
Growth hormones
Prescription Drug User Fee Act
Forward-looking statement
Growth hormone
Novo Nordisk
Palopegteriparatide
United States
Copenhagen
Ascendis Pharma A/S
Ascendis Pharma
HGH
Denmark

Click the tags to see associated articles and topics

View Article Details